Healthcare and pharma companies hold a lot of promise in the present landscape, where most countries have high aging demographics. Though some
Categories
Other Industries
Fastenal sees a dip despite beating Q3 estimates
Fastenal Company (FAST) topped market expectations on sales and profits for the third quarter of 2018 but shares still dropped over 2.5%
Earnings Preview: Fastenal likely to beat Q3 results on strong demand
Fastenal Company (FAST) is scheduled to report its quarterly earnings results for the third quarter ended September 30, 2018, on Wednesday before
Pharmacy growth might aid Walgreens to deliver upbeat Q4 results
Walgreens Boots Alliance (WBA) sales from its pharmacy stores are likely on the upward growth for the recently completed fourth-quarter as analysts
Record traffic growth may help Delta fly past fuel woes in Q3
Delta’s (DAL) persistent efforts to enhance operational efficiency paid off well in the recent quarters when the airline recorded strong results despite
AZZ Q2 profit jumps 15%, yet misses estimates
AZZ Inc. (AZZ) reported a 15% jump in earnings for the second quarter driven by strengths in its Energy and Metal Coatings
Tilray, Canopy Growth could emerge winners in a year’s time
Tilray’s (TLRY) enthusiastic IPO in July and the stock’s subsequent high jump to $13.27 billion valuation have put the entire cannabis industry
General Electric gets an upgrade from Barclays
General Electric’s (GE) stock was given a rating of Overweight by Barclays who set its price target at $16. Last week, RBC
It’s time to look at cryptos from a different perspective
There is no doubt Bitcoin and the many cryptos that mushroomed after its success enjoyed the patronage of some serious investors since
America’s largest mattress company files for bankruptcy protection
Mattress Firm, the biggest retailer of beds in the US, on Friday filed for Chapter 11 bankruptcy protection in a move to
Promising diabetes drug gives Eli Lilly a shot in the arm
Pharma giant Eli Lilly & Co. (LLY) has reported positive results from the mid-stage clinical trial of its new diabetes drug, which
Resources Connection gains on upbeat Q1 results
Resources Connection (RECN) reported a 171% jump in earnings for the first quarter helped by strategic revenue growth and management of costs
RPM’s Q1 profit plunges due to higher costs
RPM International (RPM) reported its first quarter results before the bell. Adjusted earnings came in at $0.76 per share which missed analysts’
Homebuilding, CalAtlantic merger boost Lennar’s Q3 results
Real estate firm Lennar Corp. (LEN) reported an increase in third-quarter earnings as strong homebuilding operations and contributions from the recently acquired
Landec Q1 profit dips 91%, yet tops estimates
Landec Corporation (LNDC) reported a 91% dip in earnings for the first quarter due to higher labor, packaging and freight costs and
Paychex results beat estimates in Q1
Payroll services company Paychex (PAYX) reported better-than-expected results during the first quarter, helped by solid growth in human capital management products. Revenue
Pfizer’s long-time CEO Ian Read to hand over reins to Albert Bourla
There were announcements from two giant companies in different sectors about the change in their CEOs Monday morning; pharma giant Pfizer (PFE)
John Flannery steps down as GE names new CEO and Chairman
[caption id="attachment_13176" align="alignleft" width="200"] Lawrence Culp, new CEO Image Courtesy: GE[/caption] General Electric (GE) appointed Lawrence Culp, Jr., the current board
Aceto stock plummets post disappointing earnings
Aceto Corporation (ACET) reported fourth quarter earnings that failed to meet analyst estimates, resulting in the stock dwindling about 8% during midday.
Vail Resorts falls on revenue miss
Mountain resort company Vail Resorts (MTN) reported a wider loss in the fourth quarter, hurt by higher operating expenses. Though the bottom
AngioDynamics stock plummets on Q1 earnings miss
AngioDynamics (ANGO) reported first quarter earnings of $0.16 per share, which missed analyst estimates. However, the medical device maker’s top line surpassed